"Serenoa" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A plant genus in the family ARECACEAE, order Arecales, subclass Arecidae. The fruit or the extract (Permixon) is used for PROSTATIC HYPERPLASIA.
| Descriptor ID |
D028024
|
| MeSH Number(s) |
B01.650.940.800.575.912.250.093.750
|
| Concept/Terms |
Serenoa repens- Serenoa repens
- Serenoa repen
- repens, Serenoa
- Sabal serrulata
- Sabal serrulatas
- serrulatas, Sabal
- Serenoa serrulata
- Serenoa serrulatas
- serrulata, Serenoa
|
Below are MeSH descriptors whose meaning is more general than "Serenoa".
Below are MeSH descriptors whose meaning is more specific than "Serenoa".
This graph shows the total number of publications written about "Serenoa" by people in this website by year, and whether "Serenoa" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 1 | 0 | 1 |
| 2018 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Serenoa" by people in Profiles.
-
Efficacy and safety of a hexanic extract of Serenoa repens (Permixon® ) for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH): systematic review and meta-analysis of randomised controlled trials and observational studies. BJU Int. 2018 12; 122(6):1049-1065.
-
Serenoa repens + selenium + lycopene vs tadalafil 5 mg for the treatment of lower urinary tract symptoms secondary to benign prostatic obstruction: a Phase IV, non-inferiority, open-label, clinical study (SPRITE study). BJU Int. 2018 08; 122(2):317-325.
-
Clinically Meaningful Improvements in LUTS/BPH Severity in Men Treated with Silodosin Plus Hexanic Extract of Serenoa Repens or Silodosin Alone. Sci Rep. 2017 11 09; 7(1):15179.